Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Debt / NOTE 0.750%10/1
-
Market price (% of par)
-
119.95%
-
Total 13F principal
-
$374,476,000
-
Principal change
-
-$6,094,002
-
Total reported market value
-
$449,657,000
-
Number of holders
-
43
-
Value change
-
-$2,656,918
-
Number of buys
-
15
-
Number of sells
-
26
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 as of Q3 2016
As of 30 Sep 2016 BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 had 43 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $374,476,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, OAKTREE CAPITAL MANAGEMENT LP, MACKAY SHIELDS LLC, Partner Fund Management, L.P., CALAMOS ADVISORS LLC, CREDIT SUISSE AG/, JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, and SHENKMAN CAPITAL MANAGEMENT INC.
This table shows 43 bond principal holders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.